Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1316
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00973440 | Computer-Based Comprehensive Geriatric Assessment in Oncology for Individuals 70 or Older With Gastrointestinal Malignancies | ||
| NCT00137774 | Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors | ||
| NCT06786104 | Video Inspired Discussions About Ethical Outcomes in Pediatrics | ||
| NCT00140504 | Preventing Adverse Drug Events With PatientSite | ||
| NCT03709225 | Mindfulness-Music Intervention for Adolescents and Young Adults With Cancer | ||
| NCT01853748 | T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) | ||
| NCT01754389 | Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant | ||
| NCT02423148 | Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer | ||
| NCT05057247 | Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC | ||
| NCT04040725 | Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression | ||
| NCT03122717 | Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer | ||
| NCT03495323 | A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Solid Tumors | ||
| NCT03429803 | DAY101 In Gliomas and Other Tumors | ||
| NCT00637689 | Improving Outcomes Assessment in Chronic GVHD | ||
| NCT05366413 | Early Interventional Treatment for Cancer Pain | ||
| NCT02355340 | Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fracture | ||
| NCT07735442 | BRIDGE-SIC Efficacy Trial | ||
| NCT00200161 | Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma | ||
| NCT00165386 | MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients | ||
| NCT02337491 | Pembrolizumab +/- Bevacizumab for Recurrent GBM | ||
| NCT04043845 | ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies | ||
| NCT04485767 | RESIST-ADT (Androgen Deprivation Therapy) | ||
| NCT02244463 | A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer | ||
| NCT02724878 | Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma | ||
| NCT00126191 | Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma | ||
| NCT03244826 | Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation | ||
| NCT07232043 | ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs | ||
| NCT00442130 | Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination | ||
| NCT01243619 | FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal Cancer | ||
| NCT04201145 | Pembrolizumab + Defactinib In Pleural Mesothelioma | ||
| NCT00859222 | LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma | ||
| NCT00113828 | Non-Myeloablative HLA-Matched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies | ||
| NCT03075072 | Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial | ||
| NCT00006107 | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | ||
| NCT05600101 | Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation | ||
| NCT03483012 | Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis | ||
| NCT02268175 | Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate | ||
| NCT01642186 | Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) | ||
| NCT03101254 | LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma | ||
| NCT07517666 | Genetic Information for Families After Tumor Testing Study | ||
| NCT01568346 | Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy | ||
| NCT00459069 | The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma | ||
| NCT05287347 | Panc CA Risk Model & Biomarker Testing In High-Risk Cohort | ||
| NCT01228435 | IPI-504 in NSCLC Patients With ALK Translocations | ||
| NCT00585507 | Efficacy and Safety of 500mg of Fulvestrant | ||
| NCT07112287 | Germline Testing for Predisposition to Myeloid Malignancies | ||
| NCT00095875 | Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) | ||
| NCT00047281 | Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma | ||
| NCT01207492 | Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor | ||
| NCT00153907 | Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer |
